GlassScriptPhysician profile
Muna Abuerreish
NPI 1790870020
$3,150.80
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,129 · 2020: $716 · 2021: $1,033 · 2022: $225 · 2023: $48.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $548.70 | 2019-2022 | |
| Janssen Biotech, INC. | $510.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $475.78 | 2019-2022 | |
| Gilead Sciences, INC. | $375.66 | 2019-2022 | |
| Melinta Therapeutics, LLC | $184.63 | 2019-2021 | |
| Abbvie INC. | $178.87 | 2021-2023 | Mavyret |
| Napo Pharmaceuticals INC | $157.96 | 2019-2021 | |
| Astellas Pharma US INC | $138.35 | 2019 | |
| Insmed, INC. | $121.28 | 2020-2021 | |
| La Jolla Pharmaceutical Company | $107.09 | 2020-2021 | |
| Theratechnologies INC. | $81.87 | 2019 | |
| Janssen Products, LP | $69.99 | 2019 | |
| Mylan Institutional INC. | $47.23 | 2019 | |
| Nabriva Therapeutics, Plc | $34.06 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $22.96 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $20.09 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.43 | 2022 | |
| Shionogi INC | $16.18 | 2021 | |
| Shire North American Group INC | $15.64 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.99 | 2021 | |
| Allergan, INC. | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muna Abuerreish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.